Adverse drug reaction related to drug shortage: A retrospective study on the French National Pharmacovigilance Database.
adverse drug reaction
drug shortage
medication error
pharmacovigilance
Journal
British journal of clinical pharmacology
ISSN: 1365-2125
Titre abrégé: Br J Clin Pharmacol
Pays: England
ID NLM: 7503323
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
revised:
08
09
2022
received:
12
07
2022
accepted:
16
09
2022
pubmed:
1
10
2022
medline:
17
2
2023
entrez:
30
9
2022
Statut:
ppublish
Résumé
Drug shortages are a growing global health issue. The aim of the study was to evaluate the consequences of drug shortages on patient safety based on data recorded in the French National Pharmacovigilance Database. All cases involving drug shortages reported from 1985 to the end of 2019 were extracted from the database. Following the selection process, 462 cases were included. The number of cases increased significantly from 2004 to 2019. Cases mainly involved drugs from the nervous system (22.1%, 95% confidence interval [CI] 17.5-27.0%), the cardiovascular system (16.4%, 95% CI 11.9-21.4%) and anti-infectives for systemic use (14.3%, 95% CI 9.7-19.2%) ATC classes. Most of the cases reported an adverse drug reaction (ADR) belonging to the SOC nervous system (21%, 95% CI 18-24%), skin and subcutaneous (14%, 95% CI 11-17%), general (13%, 95% CI 10-17%) and gastrointestinal (8%, 95% CI 5-11%) disorders. Disease worsening was observed in 15.9% of the cases, mostly related to a lack of efficacy of the replacement drug. Half of the cases were considered as serious. Evolution was favourable in 79.4% of the cases. Death and/or life-threatening situations were reported in 5.8% of the cases. Medication errors (MEs) were identified in 51 cases (11%), mostly occurring at the administration step and involving a human factor. This study emphasizes the clinical impact of drug shortage in terms of ADRs, ME and inefficiency. These observations underline the importance of a global health policy programme to limit the occurrence of drug shortages and to reinforce the information provided to patients and health care professionals in this context to limit risk.
Substances chimiques
Pharmaceutical Preparations
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1080-1088Informations de copyright
© 2022 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
Références
Stolar MH. Drug shortages. Science. 1976;192(4235):94. doi:10.1126/science.192.4235.94.a
Shukar S, Zahoor F, Hayat K, et al. Drug shortage: causes, impact, and mitigation strategies. Front Pharmacol. 2021;12:693426. doi:10.3389/fphar.2021.693426
Poulsen JH, Nørgaard LS, Dieckmann P, Clemmensen MH. Time spent by hospital personnel on drug changes: a time and motion study from an in- and outpatient hospital setting. PLoS ONE. 2021;16(2):e0247499. doi:10.1371/journal.pone.0247499
Cherif Chefchaouni A, Moutaouakkil Y, Adouani B, Tadlaoui Y, Lamsaouri J, Bousliman Y. Impact of anti-cancer drugs shortages in oncology and hematology departments in a Moroccan hospital. J Oncol Pharm Pract. 2022;28(4):822-826. doi:10.1177/10781552211008212
Messinger YH, Maxa KL, Hennen EM, Gossai NP, Hoff DS. Intrathecal methotrexate containing the preservative benzyl alcohol erroneously administered in pediatric leukemia patients: clinical course and preventive process. J Pediatr Pharmacol Ther. 2020;25(4):328-331. doi:10.5863/1551-6776-25.4.328
Kosarek L, Hart SR, Schultz L, Digiovanni N. Increase in venous complications associated with etomidate use during a propofol shortage: an example of clinically important adverse effects related to drug substitution. Ochsner J. 2011;11(2):143-146.
de Oliveira GS, Theilken LS, McCarthy RJ. Shortage of perioperative drugs: implications for anesthesia practice and patient safety. Anesth Analg. 2011;113(6):1429-1435. doi:10.1213/ANE.0b013e31821f23ef
Golembiewski J. Drug shortages in the perioperative setting: causes, impact, and strategies. J Perianesth Nurs. 2012;27(4):286-292. doi:10.1016/j.jopan.2012.05.005
Meloni ST, Chaplin B, Idoko J, et al. Drug resistance patterns following pharmacy stock shortage in Nigerian Antiretroviral Treatment Program. AIDS Res Ther. 2017;14(1):58. doi:10.1186/s12981-017-0184-5
Benhabib A, Ioughlissen S, Ratignier-Carbonneil C, Maison P. The French reporting system for drug shortages: description and trends from 2012 to 2018: an observational retrospective study. BMJ Open. 2020;10(3):e034033. doi:10.1136/bmjopen-2019-034033
EAHP. EAHP's 2018 survey on medicines shortages to improve patient outcomes [Internet]. www.eahp.eu/sites/default/files/report_medicines_shortages2018.pdf. Accessed April 29, 2022.
Miljković N, Gibbons N, Batista A, Fitzpatrick RW, Underhill J, Horák P. Results of EAHP's 2018 survey on medicines shortages. Eur J Hosp Pharm. 2019;26(2):60-65. doi:10.1136/ejhpharm-2018-001835
American Hospital Association. AHA survey on drug shortages [Internet]. www.aha.org/system/files/content/11/drugshortagesurvey.pdf. Accessed April 29, 2022.
Dill S, Ahn J. Drug shortages in developed countries-reasons, therapeutic consequences, and handling. Eur J Clin Pharmacol. 2014;70(12):1405-1412. doi:10.1007/s00228-014-1747-1
Institute for Safe Medication Practices. Drug shortages: national survey reveals high level of frustration, low level of safety [Internet]. www.ismp.org/resources/special-issue-drug-shortages-national-survey-reveals-high-level-frustration-low-level. Accessed October 8, 2022.
McBride A, Holle LM, Westendorf C, et al. National survey on the effect of oncology drug shortages on cancer care. Am J Health Syst Pharm. 2013;70(7):609-617. doi:10.2146/ajhp120563
Auffret M, Tyvaert L, Laroche ML, et al. Drug shortage may have serious outcome: the French exemple of phenytoine. Therapie. 2015;70(4):377-380. doi:10.2515/therapie/2015018
Becker DJ, Talwar S, Levy BP, et al. Impact of oncology drug shortages on patient therapy: unplanned treatment changes. J Oncol Pract. 2013;9(4):e122-e128. doi:10.1200/JOP.2012.000799
Hedlund NG, Isgor Z, Zwanziger J, et al. Drug shortage impacts patient receipt of induction treatment. Health Serv Res. 2018;53(6):5078-5105. doi:10.1111/1475-6773.13028
Goldsack JC, Reilly C, Bush C, et al. Impact of shortages of injectable oncology drugs on patient care. Am J Health Syst Pharm. 2014;71(7):571-578. doi:10.2146/ajhp130569
Gupta S, Wang C, Raetz EA, et al. Impact of asparaginase discontinuation on outcome in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. J Clin Oncol. 2020;38(17):1897-1905. doi:10.1200/JCO.19.03024
Witjes JA, Dalbagni G, Karnes RJ, et al. The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancer. Urol Oncol. 2016;34(11):484.e19-484.e25. doi:10.1016/j.urolonc.2016.05.033
Rentsch CA, Birkhäuser FD, Biot C, et al. Bacillus Calmette-Guérin strain differences have an impact on clinical outcome in bladder cancer immunotherapy. Eur Urol. 2014;66(4):677-688. doi:10.1016/j.eururo.2014.02.061
Vail E, Gershengorn HB, Hua M, Walkey AJ, Rubenfeld G, Wunsch H. Association between US norepinephrine shortage and mortality among patients with septic shock. JAMA. 2017;317(14):1433-1442. doi:10.1001/jama.2017.2841
Haider A, Qian Y, Lu Z, et al. Implications of the parenteral opioid shortage for prescription patterns and pain control among hospitalized patients with cancer referred to palliative care. JAMA Oncol. 2019;5(6):841-846. doi:10.1001/jamaoncol.2019.0062